All News

Nearly 1-in-5 adults with epilepsy show symptoms of attention deficit hyperactivity disorder.

The Generic Pharmaceutical Association announced today that Ralph G. Neas, President and CEO, would be stepping down from his position in the fall of 2015.

In response to the announcement of a new healthcare program in the State of the Union address last night, and in recognition of ongoing Congressional initiatives related to healthcare innovation, National Association of Chain Drug Stores President and CEO Steven C. Anderson, IOM, CAE issued this statement.

FDA Drug Info Rounds, a series of online videos, provides important and timely drug information to practicing clinical and community pharmacists so they can help patients make better decisions.

Food and Drug Administration (FDA) recently approved (PDF) DylojectTM Injection, a proprietary nonsteroidal anti-inflammatory drug meant for adults to manage mild to moderate pain and moderate to severe pain alone or in combination with opioid analgesics.

New Mexico State Senator Michael Padilla plans to sponsor legislation that would require retail pharmacies to start collection programs for unused medications.

FDA has unveiled a new database that houses most FDA guidance documents for regulatory professionals.

The FDA today approved Novartis' secukinumab (Cosentyx), an interleukin-17A antagonist, for the treatment of moderate-to-severe plaque psoriasis in adults who are candidates for systemic therapy or phototherapy.

Community pharmacists can identify and educate patients at high risk for acute kidney injury related to use of nonsteroidal anti-inflammatory drugs.

Process may reduce bowel obstructions and surgeries.

Although teixobactin is ineffective against most gram-negative organisms, its potent activity against gram-positive organisms, including vancomycin-resistant enterococci, may help delay the postantibiotic era by decades.

A pharmacist in Hoboken, New Jersey, was arrested for allegedly stealing morphine, fentanyl, and hydromorphone from his employer, Hoboken University Medical Center.

With Americans' use of opioids increasing, a panel from the National Institutes of Health set out to measure the drugs' effectiveness in treating long-term chronic pain, and its report suggested that the risks outweigh the benefits.

Pharmacists' antibiotic dispensing practices are improved through multifaceted educational interventions.

Gedeon Richter and Actavis today announced positive results from a phase 3 trial evaluating the efficacy and safety of cariprazine, an investigational atypical antipsychotic, in preventing relapse among schizophrenia patients.

It is not inconceivable that a physician who denies requests for opiates may not receive favorable ratings, which may impact their hospital privileges.

Beneficiary Advisory Panel Decision Sets Stage for Continued Coverage; Final Decision Rests with TRICARE Management Activity Director

A new FDA-approved drug will provide a new treatment option for adult and pediatric patients undergoing continuous renal replacement therapy.

Thoughts influence the mood swings of patients with bipolar disorder.

If you've ever been asked to fill a "genetic subscription" or had a patient confuse hydrocortisone with hydrocodone, then you know that pharmacy-related mispronunciations can be a recipe for hilarity.

Study warns there is no testing to support a net clinical benefit.

Pharmacists can play a vital role by finding financial aid through foundations and co-pay programs.

Most caregivers cannot make informed decisions about OTC painkillers based on information provided in the products' labels and inserts.

A Walgreens pharmacist in Rutland, Vermont, was convicted on 2 misdemeanor charges of unlawful possession of narcotics.

A University of Florida study revealed that immunizing school children against influenza produces a ripple effect of fewer flu cases among the larger community.

Even a hospital pharmacist can be misinformed when it comes to vaccinations and the decision to vaccinate their own child.